Paediatric kidney transplantation

References

• Fine R, Ettenger R. Renal transplantation in children. Kidney Transplantation, 4th edn., P Morris. WB Saunders, Philadelphia 1996; 412–60
   Google Scholar
• Kohaut E, Tejani A. The 1994 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1996; 10: 422–34
   PubMed Web of Science ®Google Scholar
• Valderrabano F, Jones E, Mallick N. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995; 10(Suppl 5)1–25
   PubMed Web of Science ®Google Scholar
• Broyer M, Ehrich J, Jones E, Selwood N. Five year survival of kidney transplantation in children: data from the European (EDTA-ERA) registry. Kidney Int 1993; 44(Suppl 43)S22–5
   Google Scholar
• Honda M, Iitaka K, Kawaguchi H, et al. The Japanese National Registry data on pediatric CAPD patients: a ten year experience. Peril Dial Int 1996; 16: 269–75
   PubMed Web of Science ®Google Scholar
• Warady B, Sullivan E, Alexander S. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int 1996; 49: S68–71
   Web of Science ®Google Scholar
• Von Lilien T, Salusky I, Boechat I, Ettenger R, Fine R. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children. J Pediatr 1987; 111: 513–8
   PubMed Web of Science ®Google Scholar
• Morel P, Almond P, Matas J, et al. Long-term quality of life after kidney transplantation in childhood. Transplantation 1991; 52: 47–51
   PubMed Web of Science ®Google Scholar
• Apajasalo M, Rautonen J, Sintonen H, Holmberg C. Quality of life after organ transplantation in childhood. Abstracts of the 2nd International Congress on Pediatric Organ Transplantation. Pediatr Nephrol 1996; 10: C69
   Google Scholar
• Haberman J, Karwa G, Greenstein S, et al. Male fertility in cyclosporine-treated renal transplant recipients. J Urol 1991; 145: 294–6
   PubMed Web of Science ®Google Scholar
• Schover L, Novick A, Steinmuller D, Goormastic M. Sexuality, fertility and renal transplantation: a survey of survivors. J Sex Marital Ther 1990; 16: 3–13
   PubMed Web of Science ®Google Scholar
• Varis J. Cost-effectiveness Analysis of Renal Replacement Therapies. Acta Universitatis Tamperensis. Series A, No 424, University of Tampere, TampereFinland 1994
   Google Scholar
• Laine J, Leijala M, Jalanko H, et al. Renal transplantation in children with emphasis on young patients. Pediatr Nephrol 1994; 8: 313–9
   PubMed Web of Science ®Google Scholar
• Broyer M, Selwood N, Brunner F. Recurrence of primary renal disease of renal on kidney graft: a European pediatric experience. J Am Soc Nephrol 1992; 2: S255–7
   Web of Science ®Google Scholar
• Cameron J. Recurrent primary disease and de novo nephritis following renal transplantation. Pediatr Nephrol 1991; 5: 412–21
   PubMed Web of Science ®Google Scholar
• Habib R, Gagnadoux M, Broyer M. Recurrent glomerulonephritis in transplanted children. Contrib Nephrol 1987; 55: 123–35
   PubMedGoogle Scholar
• Cecka J, Terasaki P. The UNOS scientific renal transplant registry. Clinical Transplants, J Cecka, P Terasaki. UCLA Tissue typing laboratory, Los Angeles 1996; 1–18, 1995
   Google Scholar
• Najarian J, Chavers B, McHugh L, Matas A. Twenty years or more of follow-up of living related donors. Lancet 1992; 340: 1450–4
   Web of Science ®Google Scholar
• Cecka J, Terasaki P. The UNOS scientific renal transplant registry. Clinical Transplants, J Cecka, P Terasaki. UCLA Tissue typing laboratory, Los Angeles 1993; 1–16, 1992
   Google Scholar
• McEnery P, Stablein D, Arbus G, Tejani A. Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. N Eng J Med 1992; 326: 1727–32
   PubMed Web of Science ®Google Scholar
• Brenner B, Cohen R, Milford E. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162–9
   PubMed Web of Science ®Google Scholar
• Didlake D, Dreyfus K, Kerma R, VanBuren C, Kahan B. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplant recipients. Transplant Proc 1988; 20: 63–9
   PubMed Web of Science ®Google Scholar
• Harmon W E, Stablein D, Alexander S, Tejani A. Graft thrombosis in pediatric renal transplant recipients. Transplantation 1991; 51: 406–12
   PubMed Web of Science ®Google Scholar
• Harmon W. Vascular thrombosis: scope of the problem in kidney transplantation. Abstracts of the 2nd International Congress on Pediatric Transplantation. Pediatr Nephrol 1996; 10: C34
   Google Scholar
• Handschumacher R E, Harding M W, Rice J, Drugge R J. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984; 226: 544–7
   PubMed Web of Science ®Google Scholar
• Liu J, Farmer J, Lane W, Friedman J, Weissman I, Schreiber S L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807–15
   PubMed Web of Science ®Google Scholar
• Schreiber S, Crabtrec G. The mechanism of action of cyclosporine A and FK 506. Immunol Today 1992; 13: 136–42
   PubMedGoogle Scholar
• Fuleihan R, Ramesh N, Horner A, et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 1994; 93: 1315–20
   PubMed Web of Science ®Google Scholar
• Cayabyab M, Phillips J H, Lanier L L. CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol 1994; 152: 1523–31
   PubMed Web of Science ®Google Scholar
• Ochiai T, Nagata M, Nakajima K, et al. Studies on the effects of FK506 on renal allografting in the beagle dog. Transplantation 1987; 44: 729–33
   PubMed Web of Science ®Google Scholar
• Ellis D. Clinical use of tacrolimus (FK506) in infants and children with renal transplants. Pediatr Nephrol 1995; 9: 487–4
   PubMed Web of Science ®Google Scholar
• Scheinman R, Cogswell P, Lofquist A, Baldwin A. Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283–6
   PubMed Web of Science ®Google Scholar
• Auphan N, DiDonato J, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kB activity trough induction of IkBa synthesis. Science 1995; 270: 286–90
   PubMed Web of Science ®Google Scholar
• Jackson R, Weber G, Harris H. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 1975; 256: 331–3
   PubMed Web of Science ®Google Scholar
• Sollinger H W. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225–32
   PubMed Web of Science ®Google Scholar
• Allison A, Eugui E, Sollinger H. Mycophenolate mofetil (RS-61443): mechanisms of action and effects in transplantation. Transplant Rev 1993; 7: 129–39
   Google Scholar
• Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection on cadaveric renal transplant. N Engl J Med 1985; 313: 337–42
   PubMed Web of Science ®Google Scholar
• Matas A, Tellis V, Quinn T, et al. Treatment of renal transplant rejection episodes in patients receiving prednisone and azathioprine. Transplantation 1985; 40: 35–9
   PubMed Web of Science ®Google Scholar
• Cockficld S, Preiksaitis J, Harvey E, et al. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lympho-proliferative disease. Transplant Proc 1991; 23: 1106–07
   PubMed Web of Science ®Google Scholar
• Patel R, Snydman D, Rubin R, et al. Cytomegalovirus propylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279–84
   PubMed Web of Science ®Google Scholar
• Deen J, Blumberg D. Infectious disease considerations in pediatric organ transplantation. Semin Pediatr Surg 1993; 2: 218–34
   PubMedGoogle Scholar
• Shapiro R, Jordan M, Fung J, et al. Kidney transplantation under FK506 immunosuppression. Transplant Proc 1991; 23: 920–3
   PubMed Web of Science ®Google Scholar
• Randhawa P, Shapiro R, Jordan M, Starzl T, Demetris A. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol 1993; 17: 60–8
   PubMed Web of Science ®Google Scholar
• Mason J. The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol 1990; 4: 554–74
   PubMed Web of Science ®Google Scholar
• Mihatsch M, Antonovych T, Bohman S -O, et al. Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 1994; 41: 23–32
   PubMed Web of Science ®Google Scholar
• Garcia D, Rennke G, Brenner B, Anderson S. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J Clin Invest 1987; 80: 867–74
   PubMed Web of Science ®Google Scholar
• Khanna A, Li B, Stenzel K, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine. Transplantation 1994; 57: 577–82
   PubMed Web of Science ®Google Scholar
• Wolf G, Neilson E. Increases in levels of collagen types I and IV mRNA in murine kidneys after treatment with ciclosporin. Nephron 1992; 60: 87–91
   PubMed Web of Science ®Google Scholar
• Muraoka K, Fujimoto K, Sun X, et al. Immunosuppressant FK506 induces interleukin-6 production trough the activation of transcription factor NF-kB: implications for FK506 nephropathy. J Clin Invest 1996; 97: 2433–9
   PubMed Web of Science ®Google Scholar
• Laine J, Holmberg C. Renal and adrenal mechanisms in cyclosporine induced hyperkalemia after renal transplantation. Eur J Clin Invest 1995; 25: 670–6
   PubMed Web of Science ®Google Scholar
• Laine J, Holmberg C. Mechanisms of hyperuricemia in renal transplanted children. Nephron 1996; 74: 318–23
   PubMed Web of Science ®Google Scholar
• Laine J, Fyhrquist F, Holmberg C. Effect of donor source on renal graft function in children on triple immunosuppression. Nephrol Dial Transplant 1994; 9: 1468–73
   PubMed Web of Science ®Google Scholar
• Hoppu K, Koskimics O, Holmberg C, Hirvisalo E L. Pharmacokinetically determined cyclosporin dosage in young children. Pediatr Nephrol 1991; 5: 1–4
   PubMed Web of Science ®Google Scholar
• Sheil A. Cancer in dialysis and transplant patients. Kidney Transplantation: Principles and Practice, 4th edn., P Morris. WB Saunders, Philadelphia 1994; 390–400
   Google Scholar
• Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719–24
   PubMed Web of Science ®Google Scholar
• Ho M, Miller G, Atchison R, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. Infect Dis 1985; 152: 876–80
   Web of Science ®Google Scholar
• Ettenger R, Marik J, Rosenthal J. Sequential therapy in pediatric cadaveric renal transplantation: a critical analysis. J Am Soc Nephrol 1992; 2: S304–6
   Web of Science ®Google Scholar
• Guest G, Broyer M. Growth after renal transplantation: correlation with immunosuppressive therapy. Pediatr Nephrol 1991; 5: 143–6
   PubMed Web of Science ®Google Scholar
• Offner G, Aschendorff C, Brodehl J. Growth after renal transplantation: an update. Pediatr Nephrol 1991; 5: 472–6
   PubMed Web of Science ®Google Scholar
• Tejani A, Fine R, Alexander S, Harmon W, Stablein D. Factors predictive of sustained growth in children after renal transplantation. J Pediatr 1993; 122: 397–402
   PubMed Web of Science ®Google Scholar
• van Diemen-Stecnvoorde R, Donckerwolcke R A, Brackel H, Wolff E D, dc Jong M C. Growth and sexual maturation in children after kidney transplantation. J Pediatr 1987; 110: 351–6
   PubMed Web of Science ®Google Scholar
• Reisman L, Lieberman K, Burrows L, Schanzer H. Follow-up of cyclosporine-treared pediatric renal allograft recipients after cessation of prednisone. Transplantation 1990; 49: 76–80
   PubMed Web of Science ®Google Scholar
• Hokken-Koelega A, Stijnen T, De Ridder M, et al. Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 1994; 343: 1313–7
   PubMed Web of Science ®Google Scholar
• Hricik D, Kupin W, First M. Steroid-free immunosuppression. J Am Soc Nephrol 1994; 4: S10–4
   Web of Science ®Google Scholar
• Sinclair N. for the Canadian Multicentre Transplant Study Group. Low dose steroid therapy in cyclosporine-treated renal transplant recipients with well-funtioning grafts. Can Med Assoc J 1992; 147: 645–55
   PubMed Web of Science ®Google Scholar
• Sarna S, Hoppu K, Neuvonen P, Laine J, Holmberg C. Methylprednisolone exposure, rather than dose, predicts adrenal suppression and growth inhibition in children with liver and renal transplants. J Clin Endocrinol Metab 1997; 82: 75–7
   PubMed Web of Science ®Google Scholar
• Hoppu K, Koskimies O, Holmberg C, Hirvisalo E L. Evidence for pre-hepatic metabolism of oral cyclosporine in children. Br J Clin Pharmacol 1991; 32: 477–81
   PubMed Web of Science ®Google Scholar
• Paradis K, O'Regan S, Seidman E, et al. Improvement in true glomerular filtration rate after cyclosporine fractionation in pediatric liver transplant recipients. Transplantation 1991; 51: 922–4
   PubMed Web of Science ®Google Scholar
• Batiuk T, Padzerka F, Enns J, et al. Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J Clin Invest 1995; 96: 1254–60
   PubMed Web of Science ®Google Scholar
• Batiuk T, Pazderka F, Halloran P. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 1995; 59: 1400–4
   PubMed Web of Science ®Google Scholar
• Shapiro R, Scantlebury B, Jordan M, et al. FK506 in pediatric kidney transplantation - primary and rescue experience. Pediatr Nephrol, in press
   Web of Science ®Google Scholar
• Ettenger R, Warshaw B, Mentser M, et al. Mycophenolate mofetil (MMF) in pediatric renal transplantation. Abstracts of the 2nd International Congress on Pediatric Transplantation. Pediatr Nephrol 1996; 10: C39
   Web of Science ®Google Scholar
• Langman L, Shapiro A, Lakey J, LeGatt D, Kneteman N, Yatschoff R. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model. Transplantation 1996; 61: 87–92
   PubMed Web of Science ®Google Scholar
• Ettenger R, Rosenthal J, Marik J, et al. Improved cadaveric renal transplant outcome in children. Pediatr Nephrol 1991; 5: 137–42
   PubMed Web of Science ®Google Scholar
• Almond P, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752–7
   PubMed Web of Science ®Google Scholar
• Basadonna G, Matas A, Gillingham K, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993–5
   PubMed Web of Science ®Google Scholar
• Guyot C, Nguyen J -M, Cochat P, et al. Risk factors for chronic rejection in pediatric renal allograft recipients. Pediatr Nephrol 1996; 10: 723–7
   PubMed Web of Science ®Google Scholar
• Laine J, Krogerus L, Jalanko H, Ronnholm K, Holmberg C. Renal allograft histology and correlation with function in children on triple therapy. Nephrol Dial Transplant 1995; 10: 95–102
   PubMed Web of Science ®Google Scholar
• Takemoto S, Terasaki P, Cecka J, Cho Y, Gjertson D. Survival of nationally shared, HLA-matched kidney trans-plants from cadaveric donors. N Engl J Med 1992; 327: 834–9
   PubMed Web of Science ®Google Scholar
• Tullius S, Hancock W, Heemann U, Azuma H, Tilney N. Reversibility of chronic renal allograft rejection. Transplantation 1994; 58: 93–9
   PubMed Web of Science ®Google Scholar
• Halloran P, Aprile M, Farewell V, et al. Early function as the principal correlate of graft survival. Transplantation 1988; 46: 223–8
   PubMed Web of Science ®Google Scholar
• Barry J, Shively N, Hubert B, Hefty T, Norman D, Bennett W. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants. Transplantation 1988; 45: 346–8
   PubMed Web of Science ®Google Scholar
• Land W, Schneeberger H, Schleibncr S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211–7
   PubMed Web of Science ®Google Scholar
• van Es A, Hermans J, van Bockel J H, Persijn G G, van Hooff J P, de Graeff J. Effect of warm ischemia time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes. Transplantation 1983; 36: 255–8
   PubMed Web of Science ®Google Scholar
• Troppmann C, Gillingham K, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation. Transplantation 1995; 59: 962–8
   PubMed Web of Science ®Google Scholar
• Brenner B, Meyer T, Hostetter T. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N EnglJ Med 1982; 307: 652–6
   PubMed Web of Science ®Google Scholar
• Rubin R, Tolkoff-Rubin N, Oliver D, et al. Multicenter sero-epidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985; 40: 243–9
   PubMed Web of Science ®Google Scholar
• Belitsky P, Gulanikar A, He G, Gupta R. The effect of immunosuppression on chronic rejection in the rat aortic allograft model. Transplant Proc 1993; 25: 935–6
   PubMedGoogle Scholar
• Dunn J, Golden D, Van Buren C, Lewis R, Louen J, Kahan B. Causes of graft loss beyond two years in the cyclosporin era. Transplantation 1990; 49: 349–53
   PubMed Web of Science ®Google Scholar
• Meyers K, Weiland H, Thomson P. Pediatric renal transplantation non-compliance. Pediatr Nephrol 1995; 9: 189–92
   PubMed Web of Science ®Google Scholar
• Korsch B, Fina R, Negrete V. Non-compliance in children with renal allografts. Pediatrics 1978; 61: 872–6
   PubMed Web of Science ®Google Scholar
• Blowey D, Hebert D, Pool R, Arbus G, Korus M, Koren G. Investigation of cyclosporine compliance in adolescent renal transplant recipients. Abstracts of the 2nd International Congress on Pediatric Transplantation. Pediatr Nephrol 1996; 10: C54
   Google Scholar
• Bosque M, Munian A, Bewick M, Haycock G, Chantler C. Growth after renal transplants. Arch Dis Child 1983; 58: 110–4
   PubMed Web of Science ®Google Scholar
• Maxwell H, Dalton R, Nair D, et al. Effects of recombinant human growth hormone on renal function in children with renal transplants. Pediatr 1996; 139: 177–83
   Google Scholar
• Kalia A, Brouhard B, Travis L, Gifford R, Winsett O. Renal transplantation in the infant and young child. Am J Dis Child 1988; 142: 47–50
   PubMedGoogle Scholar
• Powell D, Liu F, Baker B, et al. Characterization of insulinlike growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 1993; 33: 136–43
   PubMed Web of Science ®Google Scholar
• Hokken-Koelega A, Stijnen T, De Muinck Keizer-Schrama S, Blum W, Drop S. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and Cortisol in prednisone-treated children with growth retardation after renal transplantation. J Clin Endocrinol Metah 1993; 77: 932–8
   PubMed Web of Science ®Google Scholar
• Tsuzuki K, Oshima S, Ono Y, Kinukawa T, Matsuura O. Growth and kidney transplantation in children. Transplant Proc 1989; 21: 1995, 6
   PubMed Web of Science ®Google Scholar
• Ettenger R, Blifeld C, Prince H, et al. The pediatric nephrologist's dilemma: growth after renal transplantation and its interaction with age as a possible immunologic variable. j Pediatr 1987; 111: 1022–5
   PubMedGoogle Scholar
• Hooghe R, Delhase M, Vergani P, Malur A, Hooghe-Peters E. Growth hormone and prolactin are paracrine growth and differentiation factors in the haematopoietic system. Immunol Today 1993; 14: 212–3
   PubMedGoogle Scholar
• Kelley K. The role of growth hormone in modulation of the immune response. Ann N Y Acad Sci 1990; 594: 95–103
   PubMed Web of Science ®Google Scholar
• Franco P, Marelli O, Lattuada D, Locatelli V, Cocchi D, Miiller E. Influence of growth hormone on the immunosuppressive effect of prednisolone in mice. Acta Endocrinol (Copenh) 1990; 123: 339, 13
   PubMedGoogle Scholar
• Tönshoff B, Haffner D, Mehls O, et al. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Kidney Int 1993; 44: 199–205
   PubMed Web of Science ®Google Scholar
• Broyer M, Guest G, Crosnier H, Berard E. Recombinant growth hormone in children after renal transplantation. Societe Franchise de Nephrologie Pediatrique. Lancet 1994; 343: 539–40
   PubMed Web of Science ®Google Scholar
• Schwartz I D, Warady B A. Cadaveric renal allograft rejection after treatment with recombinant human growth hormone. J Pediatr 1992; 121: 664–6
   PubMed Web of Science ®Google Scholar
• Tyden G, Berg U, Reinholt F. Acute renal graft rejection after treatment with human growth hormone. Lancet 1990; 336: 1455
   PubMed Web of Science ®Google Scholar
• Chavers B, Doherty L, Nevins T, Cook M, Sane K. Effects of growth hormone on kidney function in pediatric transplant recipients. Pediatr Nephrol 1995; 9: 176–9
   PubMed Web of Science ®Google Scholar
• Christiansen J, Gammelgaard J, Orskov H, Andersen A, Telmer S, Parving H. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 1981; 11: 487–91
   PubMed Web of Science ®Google Scholar
• Hokken-Koelega A, Stijnen T, De Jong M, et al. A placebo-controlled double-blind trial of growth hormone treatment in prepubertal children with renal allografts. Kidney Int 1996; 53: S128–34
   Google Scholar
• Laine J, Krogerus L, Sarna S, Jalanko H, Ronnholm K, Holmberg C. Recombinant human growth hormone treatment: effect on renal allograft function and histology. Transplantation 1996; 61: 898–903
   PubMed Web of Science ®Google Scholar
• Cheung N, Liddle C, Coverdale S, Lon J, Boyages S. Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J Clin Endocrinol Metab 1996; 81: 1999–2001
   PubMed Web of Science ®Google Scholar